About us 

Cereprotec  Incorporated is a company involved in the development of neuroprotective drug Cereprotex.

Our Company  is also developing a family of other promising novel chemical compounds.

Proof of efficacy of these compounds has been obtained in three animal studies including hypoxia in both mice and rats and brain trauma in mice. The proof of neuroprotection concept has been shown not only for prevention (hypoxia model), but also for the treatment paradigm post brain trauma which reflects a potential realistic situation in humans.

At this moment Cereprotec Inc.  is prepared to start clinical trials and is actively seeking serious investors.

 US Patent Application No.11/723,011

to be assigned to CEREPROTEC INCORPORATED

“Method for Neuroprotection with Glycoluril Derivatives”